OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • October 2nd, 2023 • Third Harmonic Bio, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 2nd, 2023 Company Industry Jurisdiction
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL. LEASE AGREEMENT BETWEEN 130 PROSPECT LIMITED PARTNERSHIP,...Lease Agreement • March 29th, 2023 • Third Harmonic Bio, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 29th, 2023 Company Industry JurisdictionThis Lease Agreement (“Lease”) is made and entered into as of the 20th day of October, 2022, and is by and between 130 Prospect Limited Partnership, a limited partnership duly qualified to do business in the Commonwealth of Massachusetts (hereinafter sometimes referred to as “Landlord” or “Owner”) and Third Harmonic Bio, Inc., a Delaware corporation (hereinafter sometimes referred to as “Tenant”).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL. WATERFRONT PLAZA SAN FRANCISCO, CALIFORNIA OFFICE LEASE...Office Lease Agreement • March 29th, 2023 • Third Harmonic Bio, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 29th, 2023 Company IndustryTHIS OFFICE LEASE AGREEMENT (this “Lease”) is entered into as of October 19, 2022, by and between JPPF WATERFRONT PLAZA, L.P., a Delaware limited partnership (“Landlord”), and Third Harmonic Bio, Inc., a Delaware corporation (“Tenant”).
October 24, 2023 VIA EMAIL Adrian S. RaySeparation Agreement • March 26th, 2024 • Third Harmonic Bio, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 26th, 2024 Company Industry JurisdictionThis letter confirms the agreement (“Agreement”) between you and Third Harmonic Bio, Inc. (the “Company”) concerning the terms of your separation and offers you the separation benefits we discussed in exchange for your provision of Transition Services (defined below) and a general release of claims and covenant not to sue following completion of the Transition Services.